2022 annual financial data
Aspire Biopharma Holdings 2022 Operating margin
Aspire Biopharma Holdings 2022 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -976,345 USD and net income was 3,340,000 USD.
Operating cash flow was -1,408,786 USD.
Get free Aspire Biopharma Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -976,345 USD
- Net income
- 3,340,000 USD
- Operating cash flow
- -1,408,786 USD